Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Ink, Adhesive and Material Issues in Cold Chain Labelling

Posted on November 23, 2025November 23, 2025 By digi


Ink, Adhesive and Material Issues in Cold Chain Labelling: A GDP Tutorial for Pharma Supply Chain

Managing Ink, Adhesive and Material Issues in Cold Chain Labelling: A Step-by-Step GDP Guide

Effective labelling is a critical control point within the pharmaceutical cold chain, directly impacting product integrity, compliance, and patient safety. Ensuring that inks, adhesives, and labelling materials perform reliably under cold chain conditions is essential to meet regulatory expectations from authorities such as the US FDA, EMA, MHRA, and PIC/S. This tutorial provides a comprehensive step-by-step guide for pharma professionals managing GDP, warehousing, logistics validation, and pharma distribution within the pharma supply chain focused on cold chain environments. Particular attention is given to mitigating risks related to

temperature excursions, selecting appropriate materials, and validating supply chain processes including third-party logistics partners (3PL).

Step 1: Understand the Regulatory and GDP Context for Cold Chain Labelling

Before selecting inks, adhesives, and materials for labelling in the cold chain, it is essential to understand relevant regulatory frameworks and Good Distribution Practice (GDP) requirements that govern pharma supply chains in the US, UK, and EU.

Key regulatory references include FDA 21 CFR Parts 210 and 211 for labelling compliance in the United States, EU GMP Annex 15 controlling qualification and validation of labelling materials and processes within the European Union, and PIC/S guidance documents addressing supply chain and temperature controlled logistics.

GDP guidance from the European Medicines Agency (EMA) and MHRA specify that labels must remain legible, firmly adhered, and accurately reflect storage conditions throughout the distribution process, even under temperature extremes that may be encountered during cold chain transportation and warehousing. This includes full traceability of materials, adherence to batch record integrity, and controlled processes for handling temperature excursions.

Understanding the regulatory background ensures that decisions on ink type, adhesive formulation, and substrate materials support compliance with labelling requirements and quality standards throughout the cold chain.

Also Read:  Root Cause Analysis for Distribution Failures: Transport, Packaging and Human Error

For more on GDP compliance requirements, refer to the EMA GDP Guidelines.

Step 2: Select Appropriate Ink Formulations for Cold Chain Labelling

The ink used for pharmaceutical labels in cold chain environments must withstand exposure to low temperatures, moisture, and possible condensation without degradation of print quality or legibility. This step includes understanding ink chemistry, environmental stressors, and potential regulatory constraints.

Types of Inks Suitable for Cold Chain

  • Solvent-Based Inks: Offer excellent adhesion and durability but may contain volatile organic compounds (VOCs) requiring environmental controls.
  • UV-Curable Inks: Provide rapid curing and strong bonding suitable for plastic substrates commonly used in cold chain labelling.
  • Water-Based Inks: Environmentally friendly but may be less resistant to moisture and cold conditions unless specifically formulated for pharmaceutical use.
  • Thermal Transfer Ribbons: Often used for barcodes and variable data printing with superior resistance to freeze/thaw cycles.

It is critical to validate that selected inks do not fade, smudge, or crack after exposure to temperatures as low as -80°C for some clinical or biologics logistics, as well as typical 2-8°C cold chain conditions.

Testing and Validation of Ink Performance

Test labelling print samples on final substrate materials under simulated cold chain conditions. This should include freeze/thaw cycling, humidity exposure, abrasion resistance, and chemical resistance to cleaning agents used in warehousing or transport. Parameters to monitor include:

  • Color fastness and print legibility
  • Resistance to smudging or rubbing
  • Adherence stability after temperature cycling
  • Compatibility with barcode scanning technologies

Conduct ink qualification supported by documented protocols as part of logistics validation and change control procedures. Inks should also comply with pharmacopeial and safety standards to prevent contamination or toxicity risks.

Step 3: Choose Adhesives Compatible with Cold Chain Conditions

Adhesive selection is pivotal in cold chain labelling as it influences how labels adhere to packaging under refrigeration, freezing, and varying humidity levels encountered during pharma distribution. Poor adhesive selection can lead to label lifting, peeling, or complete loss causing regulatory noncompliance and traceability failures.

Types of Adhesives for Cold Chain Applications

  • Acrylic-Based Adhesives: Common for their balance of adhesion and removability but must be tested for low-temperature performance.
  • Synthetic Rubber Adhesives: Provide strong bonding even at low temperatures and under humid or wet conditions.
  • Silicone Adhesives: Used where high chemical resistance is necessary and when labels must survive extreme temperature changes.
Also Read:  Mapping Supply Chain Risks: Temperature, Counterfeiting, Mix-Ups and Delays

Adhesive selection depends on substrate compatibility, surface texture, packaging material, and expected environmental conditions throughout the cold chain.

Validation of Adhesive Performance

Conduct adhesion testing under controlled laboratory conditions replicating temperature excursions experienced during transport and warehousing. Common testing methodologies include:

  • Peel adhesion testing at temperatures from -20°C to 25°C
  • Shear adhesion resistance under temperature cycling
  • Visual inspection for label deformation or bubbling
  • Testing against condensation and moisture exposure

Ensure adhesive formulations are compatible with secondary packaging and do not migrate or cause packaging surface degradation, compromising label integrity or package sterility.

Step 4: Select Label and Substrate Materials Suitable for Cold Chain Handling

The substrate materials used for labels in cold chain applications must maintain flexibility, dimensional stability, and resistance to moisture and cold without loss of print quality or adhesive attachment. Material choice usually falls under paper-based or synthetic polymeric films.

Paper vs. Polymeric Films

  • Paper Labels: Cost-effective but vulnerable to moisture and low-temperature brittleness unless coated or laminated for cold chain use.
  • Polymeric Films (Polypropylene, Polyester, Vinyl): Provide superior resistance to temperature cycling, moisture, and mechanical stress. Preferred for cold chain due to durability.

Specialty films with frost-resistant or waterproof coatings improve label reliability during wet or frozen conditions encountered during 3PL handling and transport.

Design Considerations to Support Compliance

Ensure that label dimensions, adhesive area, and print space accommodate regulatory information including storage instructions, batch numbers, expiry dates, and handling warnings with clear typography and encoded barcodes. Surface treatments to improve ink adhesion and reduce smearing are vital for compliance during long-duration storage and transport.

Incorporate tamper-evident or security features when required by regulators or internal control policies to protect against counterfeit and ensure patient safety.

Step 5: Integrate Material and Ink Selection Within Cold Chain Logistics Validation

Once inks, adhesives, and materials are qualified, integrate their performance evaluation within formal cold chain logistics validation programs. Validation encompasses qualification of warehousing, transport conditions, and distribution processes to ensure continuous compliance and product quality.

Key Elements of Cold Chain Logistics Validation

  • Documented qualification of packaging and labelling materials under controlled temperature and humidity conditions
  • Verification of label integrity post simulated temperature excursions and freeze/thaw cycles
  • Transport qualification studies with environmental monitoring using data loggers or wireless sensors
  • Assessment and qualification of 3PL partners who manage storage, shipping, and handling
  • Routine inspection and maintenance of cold chain equipment to prevent label damage
Also Read:  GDP-Compliant Shipping Validation: Design, Execution and Documentation

Develop validated Standard Operating Procedures (SOPs) for receiving, inspecting, storing, and distributing labelled products ensuring labels remain intact and legible throughout the flow.

Refer to PIC/S PE 009-14 Guide to GDP, which extensively covers GDP requirements related to cold chain logistics and labelling controls.

Step 6: Implement Controls and Monitoring for Cold Chain Labelling in Warehousing and Distribution

Maintaining label integrity during warehousing and pharma distribution requires effective controls and continuous monitoring, as temperature fluctuations, handling, and environmental conditions can challenge labelling materials and adhesives.

Warehouse Environmental Controls

  • Strict temperature and humidity monitoring to prevent temperature excursions that could impair adhesive and ink performance
  • Use of controlled atmosphere chambers or cold rooms compliant with GDP norms including traceable documentation of conditions
  • Regular inspection schedules to identify early signs of label degradation or adhesive failure

Handling and Packaging

  • Training staff on careful handling to avoid abrasion or contamination of labels
  • Use of packaging materials to protect labels from mechanical damage or moisture ingress
  • Validated processes for labelling during repackaging or relabelling by 3PL providers

Incident Management and Continuous Improvement

Establish robust deviation management related to label performance failures, documenting root cause analyses covering materials, environmental conditions, and process adherence. Implement corrective/preventive actions (CAPA) to address weak points.

Periodic review of supplier qualifications for inks, adhesives, and label substrates is recommended to manage supply chain risks. This aligns with ICH Q7 and Q10 quality management principles supporting integrated pharmaceutical quality systems.

Step 7: Summary and Best Practices for Cold Chain Labelling Compliance

Cold chain labelling integrity hinges on a multidisciplinary approach incorporating regulatory knowledge, material science, process validation, and rigorous supply chain controls. Key best practices for pharmaceutical companies managing GDP-compliant cold chain distributions include:

  • Early engagement with regulatory requirements and GDP guidance to shape labelling strategies
  • Comprehensive qualification and validation of inks, adhesives, and substrates under simulated cold chain conditions
  • Integration of material qualifications into formal logistics validation alongside transport, warehousing, and 3PL partner management
  • Stringent environmental monitoring and staff training to minimize risks from temperature excursions and handling errors
  • Continuous performance review supported by deviation investigations to maintain label integrity throughout the product lifecycle

By following this step-by-step GDP tutorial framework, pharmaceutical professionals in the US, UK, and EU can ensure that cold chain labelling meets stringent regulatory expectations, supporting patient safety and product quality across the complex pharma supply chain.

Supply Chain, Warehousing, Cold Chain & GDP Tags:3PL, cold chain, GDP, pharma distribution, pharma supply chain, temperature excursions, warehousing

Post navigation

Previous Post: Maintaining Humidity-Controlled Storage for Hygroscopic Products
Next Post: Leveraging IoT and Digital Sensors for Real-Time GDP Compliance

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme